Free Trial

Canopy Growth Target of Unusually Large Options Trading (NASDAQ:CGC)

Canopy Growth logo with Medical background

Key Points

  • On Monday, investors purchased 26,960 call options for Canopy Growth, a 158% increase compared to its typical daily volume.
  • Canopy Growth's recent quarterly earnings revealed a loss of ($0.14) EPS, exceeding analysts' expectations but resulting in a negative net margin of 155.76%.
  • Institutional investors have shown increased interest, with TD Asset Management raising its stake by 47.3% and Centiva Capital increasing its stake by 133.1% in recent quarters.
  • MarketBeat previews top five stocks to own in October.

Canopy Growth Corporation (NASDAQ:CGC - Get Free Report) was the recipient of unusually large options trading on Monday. Traders acquired 26,960 call options on the stock. Thisrepresentsanincreaseofapproximately158% compared to the typical volume of 10,434 call options.

Canopy Growth Stock Performance

NASDAQ CGC traded down $0.19 on Friday, reaching $1.30. The stock had a trading volume of 25,245,707 shares, compared to its average volume of 20,055,266. The company has a debt-to-equity ratio of 0.59, a quick ratio of 2.10 and a current ratio of 3.07. Canopy Growth has a 12-month low of $0.77 and a 12-month high of $7.12. The business's 50-day moving average price is $1.24 and its 200 day moving average price is $1.35. The stock has a market cap of $311.81 million, a P/E ratio of -0.43 and a beta of 0.67.

Canopy Growth (NASDAQ:CGC - Get Free Report) last issued its quarterly earnings data on Friday, August 8th. The company reported ($0.14) earnings per share for the quarter, beating analysts' consensus estimates of ($0.15) by $0.01. Canopy Growth had a negative return on equity of 89.93% and a negative net margin of 155.76%. The company had revenue of $52.98 million during the quarter, compared to analysts' expectations of $64.98 million. As a group, equities analysts expect that Canopy Growth will post -2.81 earnings per share for the current year.

Institutional Investors Weigh In On Canopy Growth

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Two Sigma Securities LLC grew its holdings in Canopy Growth by 4.4% during the second quarter. Two Sigma Securities LLC now owns 280,852 shares of the company's stock worth $343,000 after acquiring an additional 11,942 shares during the period. Wealth Enhancement Advisory Services LLC grew its holdings in Canopy Growth by 81.3% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 32,336 shares of the company's stock worth $41,000 after acquiring an additional 14,498 shares during the period. Dimensional Fund Advisors LP acquired a new position in Canopy Growth during the fourth quarter worth $41,000. Mackenzie Financial Corp grew its holdings in Canopy Growth by 56.5% during the first quarter. Mackenzie Financial Corp now owns 50,413 shares of the company's stock worth $47,000 after acquiring an additional 18,202 shares during the period. Finally, Boothbay Fund Management LLC acquired a new position in Canopy Growth during the second quarter worth $30,000. Hedge funds and other institutional investors own 3.33% of the company's stock.

Wall Street Analysts Forecast Growth

CGC has been the subject of several recent analyst reports. Piper Sandler restated an "underweight" rating on shares of Canopy Growth in a research note on Friday, May 30th. Zacks Research upgraded Canopy Growth to a "hold" rating in a research note on Tuesday.

View Our Latest Report on Canopy Growth

About Canopy Growth

(Get Free Report)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments.

Featured Stories

Should You Invest $1,000 in Canopy Growth Right Now?

Before you consider Canopy Growth, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Canopy Growth wasn't on the list.

While Canopy Growth currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.